Stocks - r/Stocks Daily Discussion & Technicals Tuesday - Aug 03, 2021 |
- r/Stocks Daily Discussion & Technicals Tuesday - Aug 03, 2021
- GE made me shit myself
- Where would you put 10k today?
- Corsair Q2: EPS: $0.36 v $0.43 Revenue: $472.9M v $466M
- Alibaba Group Announces June Quarter 2021 Results
- SQ and Afterpay. Please don't fall for it seriously
- Here is a Market Recap for today Tuesday, August 3, 2021v
- ATVI Activision Blizzard up on earnings beat, mixed guidance
- Is there anyway to transfer funds from one stock to another without paying gains taxes ?
- Risky stocks for potential big gains down the road.
- Under Armour shares surge as earnings top estimates, retailer hikes outlook
- Decided to DCA $AMD but the recent spike makes me want to halt the plan
- Preparation for trading day -August 03, 2021
- Here is a Market Recap for today Monday, August 2, 2021
- How to calculate when I'll get a margin call?
- What is "holding period" w.r.t cost basis method?
- When did it become easy in the USA to buy stocks in quantities less than 100 shares?
- Chinese AAA-rated SOE made up $13.3B in cash holdings, was fined $464K, and 6 execs a combined $355K.
- Talking Pinterest.
- Imara Inc. $IMRA insider buying
- Tilray (TLRY) DD
- Would SKLZ be at a possible buying point?
- Let's assume a 20% crash happens in the next couple months. How do you leverage gains assuming there's a 6 month recovery?
- Any recommendations on audiobooks or podcasts that are good for beginners?
- Visa AMEX & Mastercard vs PayPal, square
| r/Stocks Daily Discussion & Technicals Tuesday - Aug 03, 2021 Posted: 03 Aug 2021 02:30 AM PDT This is the daily discussion, so anything stocks related is fine, but the theme for today is on technical analysis (TA), but if TA is not your thing then just ignore the theme and/or post your arguments against TA here and not in the current post. Some helpful day to day links, including news:
Technical analysis (TA) uses historical price movements, real time data, indicators based on math and/or statistics, and charts; all of which help measure the trajectory of a security. TA can also be used to interpret the actions of other market participants and predict their actions. The main benefit to TA is that everything shows up in the price (commonly known as "priced in"): All news, investor sentiment, and changes to fundamentals are reflected in a security's price. TA can be useful on any timeframe, both short and long term. Intro to technical analysis by Stockcharts chartschool and their article on candlesticks If you have questions, please see the following word cloud and click through for the wiki: See our past daily discussions here. Also links for: Technicals Tuesday, Options Trading Thursday, and Fundamentals Friday. [link] [comments]  |
| Posted: 03 Aug 2021 05:45 AM PDT I woke up and turned on CNBC and saw the crawler indicate GE at $100/share. As a former bag holder who got out at a decent loss I messed my night time knickers thinking what tf why didn't I just hold!?! Turns out there was a 8-1 reverse stock split and nothing has changed with that terrible company. Read more here: https://www.investopedia.com/terms/r/reversesplit.asp [link] [comments]  |
| Where would you put 10k today? Posted: 03 Aug 2021 08:03 AM PDT Hi all, new the sub and have been enjoying reading everybody's perspectives. I have 10k to invest today. My portfolio is currently very heavy on AAPL, which I've held for 10 years and have no intention of selling anytime soon. I'm mostly interested in longer term investments - looking at the next 5-10 years at least. What would you personally buy into today? So curious to see responses. Edit: wow I was not anticipating so much response. Thanks everyone for your thoughts except those of you who said snarky things 🙂 I love hearing your thoughts and thinking on them myself. [link] [comments]  |
| Corsair Q2: EPS: $0.36 v $0.43 Revenue: $472.9M v $466M Posted: 03 Aug 2021 04:13 AM PDT Net revenue was $472.9 million, an increase of 24.3% year-over-year. Gamer and creator peripherals segment net revenue was $155.2 million, an increase of 40.9% year-over-year. Gaming components and systems segment net revenue was $317.7 million, an increase of 17.6% year-over-year. Gross profit was $130.4 million, an increase of 24.1% year-over-year, with gross margin of 27.6%, flat year-over-year. Gamer and creator peripherals segment gross profit was $54.6 million, an increase of 41.0% year-over-year. Gaming components and systems segment gross profit was $75.7 million, an increase of 14.2% year-over-year. Net income was $27.7 million, or $0.28 per diluted share, compared to net income of $22.6 million in the same period last year, or $0.26 per diluted share. [link] [comments]  |
| Alibaba Group Announces June Quarter 2021 Results Posted: 03 Aug 2021 04:20 AM PDT BUSINESS HIGHLIGHTS In the quarter ended June 30, 2021:
Link: https://finance.yahoo.com/news/alibaba-group-announces-june-quarter-105400522.html [link] [comments]  |
| SQ and Afterpay. Please don't fall for it seriously Posted: 02 Aug 2021 05:05 PM PDT All I can say is wow - paid $30b USD for a company doing $100m EBITDA and pretty saturated in terms of user base in Australia. 20% dilution, but mkt does not care and up 10%? So it's effectively a $175b mkt cap ($275 share price x 635 diluted shares) - yea that's right - go and check how sneaky the anti dilutive shares are .... Dorsey just bailed out 2 smart Aussies and paid them $2b USD each. With the stimulus cliff now real, be prepared for weak Q3 21 results - no stimulus, no money in bank account of low income CashApp users! Toughest yoy comps - only Arkk and unsuspecting retail investors will keep buying shares at these levels, but it ain't going to end well. Fwiw, stock is on 35x Q2 21 sales i.e. with peak stimulus - one just needs to look at the balance sheet to see how flawed the thesis of Square disrupting the banks is - even with 35m actives, they have only gather $4b in deposits? Pathetic ... but makes senses - their cohort is low income and hardly saves. I can't see anyone from a well respected bank like Chase of Bank of America Prefered Rewards switching their primary banking relationship to Cashapp. Stimulus-driven tailwinds are done, and the music will stop - no wonder he had to buy Afterpay to plug the massive revenue hole that's about to come. [link] [comments]  |
| Here is a Market Recap for today Tuesday, August 3, 2021v Posted: 03 Aug 2021 01:36 PM PDT PsychoMarket Recap - Tuesday, August 3, 2021 Stocks rose today, reversing from yesterday's losses and extending the current run of day-to-day volatility. Like I said yesterday, I expect a lot of choppiness moving forward as the market participants continue to balance record corporate earnings and expectations for economic expansion with concerns surrounding the coronavirus Delta variant and inflation. Looking ahead, market participants wait for the July Jobs Report, set to be released on Friday. Concerns surrounding the highly contagious coronavirus Delta variant continue to rise, with Florida now emerging as the US' new epicenter for the disease. Cases in Florida have jumped dramatically, going from 2432 on July 1 to 38,776 on July 30 and have so far had three consecutive days of record infections. Thankfully, however, despite the surge in cases, the death rate has so far remained stable and relatively low, a sign that the vaccines are very effective at preventing hospitalizations and serious death. In the US, despite roughly 50% of the population being vaccinated, in the past two weeks, infections across the country have roughly doubled, with new cases jumping from 13,200 on July 4 to 78,433 as of July 31, according to data compiled by John Hopkins University. However, it is important to note, despite the surge the 7-day average of deaths is 360, once again according to John Hopkins University. However, it is very important to understand that cases remain highly concentrated in areas with high vaccine hesitancy, among other factors. For example, last week 1 in 3 new COVID infections came from just two states: Texas and Florida, according to the White House. While one always has to understand the risks present in the market, in my humble opinion, I don't think the Delta variant will weigh too heavily on the US economy as a whole. According to data from the CDC, 97% of people who have died or been hospitalized with COVID-19 since the vaccine became widely available are unvaccinated. Dr Rochelle Walensky, Director of CDC said of the rising cases, "There is a clear message that is coming through. This is becoming a pandemic of the unvaccinated. Our biggest concern is we are going to continue to see preventable cases, hospitalizations, and sadly deaths among the unvaccinated." Sadly, despite the widespread availability of the vaccine in the US, hesitancy in certain places remains very high. So far, 59% of the companies in the S&P 500 (SPY) have reported Q2 earnings, with 88% of these beating analyst expectations, according to FactSet. This quarter is shaping up to be another record-breaking one, with corporate earnings growth rate expected to accelerate 85%, which would be the biggest jump since the Q4 2009. However, it is important to note that, despite beating earnings expectations, a number of these companies have pulled back, with tepid outlooks moving forward overshadowing strong results. Moving forward, given that most companies have so far exceeded pre-pandemic levels and the current quarter has an easy comparison to last year, expectations for growth are inevitably going to moderate. This said, I think the pullback in some stocks following earnings is an overreaction. Highlights
"If the plan doesn't work, change the plan but never the goal." - Unknown [link] [comments]  |
| ATVI Activision Blizzard up on earnings beat, mixed guidance Posted: 03 Aug 2021 01:38 PM PDT ATVI is up about 4% after hours. Revenue was $1.92 billion versus $1.89 billion expected and EPS was $0.91 versus $0.75 expected. Q3 guidance is mixed with revenue beating analyst estimations at $1.85 billion vs $1.79 billion but EPS expected to only be $0.65 vs the expected $0.75. On recent news their company president has stepped down and Jen Oneal and Mike Ybarra are replacing him as co-leaders. [link] [comments]  |
| Is there anyway to transfer funds from one stock to another without paying gains taxes ? Posted: 03 Aug 2021 09:28 AM PDT Currently I am sitting on a substantial capital gain from CPSL (161k shares at .0002) average and after their merger is done I want to directly move my funds from them to another stock is there anyway to do that without paying gains taxes? Just thought I would ask if not it's truly not a big deal. For record I've been holding them over a year so they are considered long term. [link] [comments]  |
| Risky stocks for potential big gains down the road. Posted: 03 Aug 2021 01:37 PM PDT I know this gets posted semi-frequently, but markets move fast and so this opinion is always changing. What are some stocks that you put a fraction of your investing money in that you know is risky, but are betting for long term potential? I'll list some of mine. Rover (ROVR): Just went public via a SP@C and is the dominator in the pet sitting market. Very strong upside emerging post-Covid with people going on vacations/returning to office. Lots of COVID adoptions for pets has expanded the Rover market tremendously. Proterra (PTRA): IPO'd this year. Manufacturer of electric buses with customers ranging from colleges and universities to National Parks to cities in the US for local transportation. Also breaking into the school bus and commercial vehicle markets. Corsair Gaming (CRSR): a company from my opinion (and the opinion of many analysts) is INCREDIBLY underrated. With gaming/streaming expecting to grow rapidly over the next few years, this company provides a lot of the equipment necessary for it. Coinbase (COIN): Crypto wallet with more uses than just buying and selling cryptocurrencies. I'm a big believer in Ethereum so I like the support for DEFI and Dapps. Array Technologies (ARRY): Develops the ground mounts necessary for solar panels to move with the sun to achieve max exposure and thus better efficiency. Offices across the Americas and Europe. [link] [comments]  |
| Under Armour shares surge as earnings top estimates, retailer hikes outlook Posted: 03 Aug 2021 04:27 AM PDT https://www.cnbc.com/2021/08/03/under-armour-uaa-q2-2021-earnings.html Earnings per share: 24 cents adjusted vs. 6 cents expected Revenue: $1.35 billion vs. $1.21 billion expected The athletic apparel maker also hiked its outlook for the full year, anticipating that its momentum will build. It now expects fiscal 2021 revenue to rise at a low-20s percentage, compared with a previous forecast of a high-teen percentage increase. UAA is another good recovery play stock. As people start going out to exercise more, uaa will definitely going to benefit. Hiking the outlook is the best evidence as the management is confident that the company will outperform going forward. [link] [comments]  |
| Decided to DCA $AMD but the recent spike makes me want to halt the plan Posted: 03 Aug 2021 11:20 AM PDT Hello! I'm a new invester who only made his first investment account last winter. I've been eyeing on AMD since I first made my account but didn't really buy any until recently. Once it hit $100, I thought to myself AMD still has room to grow but there must be some correction soon after. Hence I decided to DCA 1 share per week with initial investment of 3 stocks at $104 (I know it's not a lot but I tell myself the percentage of the gain is what matters as I'll keep putting more and more money into the account). In a case like this, should I halt my DCA plan as I still believe there's going to be an inevitable correction? Or do I stick with the plan? In more general term, in mid DCA if your judgement of the state of a specific stock is that it is overpriced and hence there will be a correction, do you take the profit and try to re-enter later on? What's the strategy here? Thanks in advance! [link] [comments]  |
| Preparation for trading day -August 03, 2021 Posted: 03 Aug 2021 05:05 AM PDT Preparation for trading day -August 03, 2021Note that this only includes stocks with larger market cap and stocks considered popular. Notable Price Upgrades and DowngradesSquare (SQ):
ON Semiconductor (ON):
Restaurant Brands Intl (QSR):
Take-Two Interactive (TTWO):
ZoomInfo Technologies (ZI):
SolarEdge Technologies (SEDG):
Planet Fitness (PLNT):
Workday (WDAY):
Airbnb (ABNB):
Today's Economic Calendar
IPO market (This week)
That's all folks, have fun and stay green Disclaimer: I am not a financial advisor, and nothing in this post shall be seen as a financial advise. Always make to sure to vet the accuracy of statements and do your own research before using it in any way [link] [comments]  |
| Here is a Market Recap for today Monday, August 2, 2021 Posted: 02 Aug 2021 02:11 PM PDT PsychoMarket Recap - Monday, August 2, 2021 Stocks continued volatility from last week, with the three major indexes opening the day in the green before turning lower towards the end in the first trading session in August. As has been the case for at least a few weeks now, it seems the market will continue to perform a careful balancing act between record corporate profits and expectations for economic expansion and concerns surrounding the highly contagious coronavirus Delta variant and inflation. So far, 59% of the companies in the S&P 500 (SPY) have reported Q2 earnings, with 88% of these beating analyst expectations, according to FactSet. This quarter is shaping up to be another record-breaking one, with corporate earnings growth rate expected to accelerate 85%, which would be the biggest jump since the Q4 20009. However, it is important to note that, despite beating earnings expectations, a number of these companies have pulled back, with tepid outlooks moving forward overshadowing strong results. Moving forward, given that most companies have so far exceeded pre-pandemic levels and the current quarter has an easy comparison to last year, expectations for growth are inevitably going to moderate. This said, I think the pullback in some stocks following earnings is an overreaction. In the last few weeks, concerns over the coronavirus Delta variant are increasing, which inevitably, has injected volatility in the markets. Last week, the CDC reversed their indoor mask policy. The agency now recommends that even fully vaccinated individuals begin once again wearing masks indoors in areas with high coronavirus transmission and in K-12 schools. Dr. Rochelle Walensky, Director of the CDC said, "In areas with substantial and high transmission, CDC recommends fully vaccinated people wear masks in public, indoor settings to help prevent the spread of the delta variant, and protect others. This includes schools". As I have said before and will explain further below, while the surge in cases is unfortunate, it is important to note that the surge is largely concentrated in areas with high vaccine hesitancy. Moreover, while cases are surging, thankfully, hospitalizations and death rates are much lower when compared to previous surges, a sign that the vaccine is doing its job. While it doesn't prevent one from becoming infected, it greatly reduces the possibility for complications. In the US, despite roughly 50% of the population being vaccinated, in the past two weeks, infections across the country have roughly doubled, with new cases jumping from 13,200 on July 4 to 78,433 as of July 31, according to data compiled by John Hopkins University. However, it is important to note, despite the surge the 7-day average of deaths is 360, once again according to John Hopkins University. According to data from the CDC, 97% of people who have died or been hospitalized with COVID-19 since the vaccine became widely available are unvaccinated. Dr Rochelle Walensky, Director of CDC said of the rising cases, "There is a clear message that is coming through. This is becoming a pandemic of the unvaccinated. Our biggest concern is we are going to continue to see preventable cases, hospitalizations, and sadly deaths among the unvaccinated." Sadly, despite the widespread availability of the vaccine in the US, hesitancy in certain places remains very high. Moreover, last week, the Fed released its July Monetary Policy Report largely reiterated what members of the Fed have been saying for months, but did include some new language hinting that the economic recovery is getting closer to the Fed's stated goals. The report also acknowledged potential risks and stated the Fed was ready to act if "appropriate risks arise". The statement read, "In assessing the appropriate stance of monetary policy, the Committee will continue to monitor the implications of incoming information for the economic outlook. The Committee would be prepared to adjust the stance of monetary policy as appropriate if risks emerge that could impede the attainment of the Committee's goals. The Committee's assessments will take into account a wide range of information, including readings on public health, labor market conditions, inflation pressures and inflation expectations, and financial and international developments." Highlights
"An investment in knowledge pays the best interest." - Benjamin Franklin [link] [comments]  |
| How to calculate when I'll get a margin call? Posted: 03 Aug 2021 09:01 AM PDT Ok, pretty sure I'll catch some abuse for this question but I'm still confused after researching. I had ~$44000 in cash, I used margin to buy $66700 worth of AMZN, 20 shares total ($3335 per share). So as I understand I used 50% of my available margin. Brokerage requires 50% maintenance for "concentrated positions". So since I used $22700 of margin, AMZN would have to drop to 26.79% of original price before I'd get a margin call. As long as AMZN is above $860 per share, I'm good? [link] [comments]  |
| What is "holding period" w.r.t cost basis method? Posted: 03 Aug 2021 02:07 PM PDT Vanguard specifies various Cost Basis methods. One of them is Average cost (AvgCost), defined as follows:
Is this holding period the one that the IRS takes into account when determining whether you pay short or long-term capital gains taxes? If so, it would be easy to avoid the higher short-term capital gains tax rate - you'd only need a single 1yr old share - the rest can be any age. --- [link] [comments]  |
| When did it become easy in the USA to buy stocks in quantities less than 100 shares? Posted: 03 Aug 2021 01:34 PM PDT I assume electronic trading had something to do with it. In the 70s and 80s, you were supposed to buy stock in lots of 100 and odd lots were more expensive, thus helping the mutual fund industry. Would you say trading in odd lots became prevalent in the dot com era? [link] [comments]  |
| Posted: 02 Aug 2021 10:05 PM PDT
[link] [comments]  |
| Posted: 03 Aug 2021 06:16 AM PDT What's up guys. I've been keeping an eye on PINS for about 6 months now. I haven't bitten. I'll be trading options on it but I wanna know what you guys think of of their mid-term outlook. It just fell about 25% in the past week after an earnings reaction. I won't be touching it for a week or two but I have my eye on it closely. [link] [comments]  |
| Imara Inc. $IMRA insider buying Posted: 03 Aug 2021 07:51 AM PDT Any ideas on Imara inc? Just found this article regarding insider trading: ... IMARA, a clinical stage biopharmaceutical firm, engaged in research on Hemoglobinopathies. Specifically, the company has a drug candidate in the pipeline as a treatment for sickle cell disease and beta thalassemia. These are two blood disorders – both sets of related diseases – that cause anemic symptoms; sickle cell disease is a genetic disorder that causes misshapen red blood cells and can lead to serious quality-of-life issues and shortened life span, while beta thalassemia is a hemoglobin disorder, also inherited, that reduces the blood's ability to carry oxygen. Neither set of diseases currently has a fully effective treatment. The chief drug candidate in IMARA's pipeline, IMR-687, is a selective and potent small molecule that inhibits PDE9. PDE9, in turn, plays a part in lowering levels of cGMP in blood-disorder patients, with associated inflammation, reduced blood flow, and other symptoms. Blocking PDE9 has been associated with reactivation of fetal hemoglobin – with consequent reduction of symptoms. In June, IMARA reported final data from a Phase 2a clinical trial of IMR-687 in sickle cell disease which showed a significantly lower annualized rate of vaso-occlusive (blood flow blocking) crises (VOCs) in patients. New patients started on the drug also showed a longer time to the first VOC. IMR-687 was also well-tolerated by patients, both as a monotherapy and in combination with hydroxyurea. In insider trades, the key transaction from an investor perspective was made at the end of July by Board member Mark Chin. Chin bought 1.333 million shares for nearly $8 million. Chin's stake in the company now totals over $13.5 million. Leerink analyst Joseph Schwartz is bullish on IMRA, and takes the long-term view when assessing the company's prospects. "Although IMRA shares have been under pressure this year, we believe encouraging Ph.2a VOC data should give the stock some lift today ahead of Ph.2b interim data expected in 2H21... Ahead of interim Ph.2b ARDENT and FORTE data in 2H21, we reiterate our OP rating on IMRA," Schwartz wrote. The analyst added, "We currently estimate gross peak sales of ~$2.8B (2035E), and ~$290M (2035E) for IMR-687 in SCD and β-thalassemia, respectively. We account for clinical and regulatory risks in our probability of success (PoS) estimates, which range from 60%/40% in SCD (US/EU) to 40%/20% in βthalassemia (US/EU)." To this end, Schwartz gives IMRA shares a $42 price target – indicating true confidence, and an impressive 661% upside potential from the current share price. (To watch Schwartz's track record, click here) Overall, IMRA has received two recent Buy recommendations from the analysts, for a Moderate Buy consensus rating. (See IMRA stock analysis on TipRanks) Source: https://finance.yahoo.com/news/3-stocks-flashing-signs-strong-220741302.html [link] [comments]  |
| Posted: 03 Aug 2021 12:31 PM PDT I. Introduction This is not investment advice. I own Tilray shares myself with an average entry price of $14.97. I would like to outline some bull & bear scenarios regarding the company below, along with a general assessment and reasons why Tilray is a good stock with further growth potential. II. Numbers (mostly) do not lie First of all, I always look at the numbers when it comes to stocks, because I like to buy a solid stock for my money, apart from a few exceptions. The problem with a value approach is that stocks never trade "cheap" without a reason. The negatives are priced in, so in 99.9% of cases there is no such thing as a "cheap" company. Everything is fairly valued. Therefore, the figures can only give information about the value, if you do not look at them isolated. However, it is mandatory to know them. Regarding Tilray, it is known that the quarterly numbers far exceeded expectations. Earnings per share were $0.18, well above the forecast. But here's the first point: Tilray's EPS was -$0.09 for August 2020, -$0.37 for November 2020, and -$0.97 in February 2021. It was only after the merger with Aphria that Tilray was able to report in the black. So the question to be answered is whether Aphria helped to switch to profit. Here, in any case, a clear `no' applies with regard to EPS. Aphria had an EPS of -$1.14 in the last figures before the merger. The quarters before that were better with -$0.42 and -$0.02, but also not positive. So based on EPS alone, it cannot be said that the positive result is due to the merger with Aphria. Other Key Figures (Based on Tilray's Interim Unaudited Financial Statement for the Year ended May 31, 2021): Tilray currently has positive free cash flow at $3.3 million. Adjusted EBITDA would be $40.7 million for the year based on quarterly numbers, still positive since 2020. Revenue would be $513 million. This is all nice, but only suggests a relatively favorable price-to-sales ratio of about 12. The recently announced quarterly numbers alone only say that the black numbers (at least) are not coming solely from the merger with Aphria. This is the first time the company has presented such numbers, so little can be inferred from them going forward, except for hope and some positive indicators. III. Opportunities 1. Tilray's position in the market Tilray has become the largest cannabis producer in the world after its merger with Aphria. However, this does not mean that Tilray produces and distributes cannabis in raw form, rather Tilray has several product ranges that now serve almost the entire market. Not only medical cannabis, but also others such as craft beer or products not directly associated with the typical scope of cannabis. The market in which Tilray is currently the best positioned player is tiny compared to the market of alcohol or other raw materials for which cannabis would also be suitable (be it medical applications or textiles and food). Cannabis is explicitly permitted for consumption in two countries. For medical use, however, it is already approved in 47 countries. 2. Regulations as the main criteria for development The market that can open up here is worth tens if not hundreds of billions of dollars. Should regulations loosen, Tilray, as the largest producer, is well positioned to serve this market. With its market cap of $6.2 billion, Tilray is valued at just enough to be quickly caught up by revenues if not profits in the coming years, assuming regulations continue in the current direction. But that is also the most important keyword: regulations. If country approvals change or do not continue to develop as they have in the past, Tilray's hands are tied. There is no way to bypass them and move into other markets. 3. Other risks
Tilray is a legal company and accordingly must comply with applicable law. However, it is in direct competition with one of the largest black markets in the world, at least for one of its products. For this competitor, no laws and regulations apply, which means that Tilray has a higher price tag on its products. However, this point can easily be refuted by the fact that the price for the control and security that go hand in hand with it are out of proportion to the price premium. One would think so. But here the opinions are divided, what influence a legalization has on the black market. After some research, one could only read in not particularly named sources that the black market has become larger after legalization. But it is clear that it does not disappear. Bloomberg Canada, for example, states that the illegal market has shrunk significantly since legalization. Opinions differ, however, as to what role taxes play in this and under what circumstances people would still use the black market.
Cannabis is not subject to a patent. Other producers can serve the market just like Tilray, that can be especially Cannopy Growth, which is positioned not far behind Tilray in the market. However, if the bet on regulators works out, the market will be so enlarged that even if four big players were to serve the market, it would still far exceed the current market cap of all cannabis companies.
The cannabis market has only really started to pick up steam since 2016, and can develop quickly accordingly. This can be a risk factor for Tilray's business plan if it cannot be flexibly adjusted. But again, it should be noted that Tilray is theoretically best positioned as the largest player in the market and even if the cannabis market can evolve, the product is relatively consistent. The only problem is the price pressure in the new market. If the market grows, it is clear that prices will drop. That will have an impact on sales and profitability. In my opinion, this is the only negative argument that is really valid. Here we can only hope that similar profitability will result as with alcohol or other consumer goods stocks, and that ultimately Tilray will come out on top here due to sheer size. Tilray is thus more likely to dominate the market, as their capacity means that they in fact also have lower losses than smaller companies. 4. Conclusion Should the cannabis market open up a larger portion or possibly its full potential after loosened regulations, Tilray will be right up front. While there are a few risk factors to consider. Ultimately, though, it comes down to two things. For the short-term investors: can Tilray continue to deliver such strong numbers over the next few quarters. For the long-term investors: How will it fare with regulations around cannabis? If these are loosened, Tilray is certainly the right address to participate in the then emerging market. TL;DR: Smokes pleasantly. Good stuff, good company and therefore good stock. [link] [comments]  |
| Would SKLZ be at a possible buying point? Posted: 03 Aug 2021 10:56 AM PDT So just to be upfront, I'm new to stock trading and am still learning so I am trying to work on identifying good stocks. As of right now SKLZ is trading at around 13.40-13.50 with a market cap of 5.31B Last quarter their earnings per share and revenue beat expectations by a bit of a margin, and their newest quarterly reports will be released today at 5:30 PM. When I look at the evaluation of the analysts on my brokerage (I'm using E-Trade) they put the value at a low of 17 and an average price target of 24.50. I saw other posts about SKLZ of users who thought that the company was overvalued back when it was at 28 a share, but now that the stock has dropped, would this be a good entry point? Again, I'm still new and learning so please let me know what you think and any information you think I might have missed. Thank you! [link] [comments]  |
| Posted: 03 Aug 2021 02:53 AM PDT I'm happy with the return on my investments this year and I've cashed out. I'm sitting on cash waiting for the biggest dip in the last year. I have no idea if it will happen but I'm hoping. That being said, if I'm confident in a recovery something like covid's market recovery, how could I get the most out of my money? I'm a newer trader so my intuition tells me options might IV crush me if I wait for a major dip. How can I leverage my small savings account for the best? Or should I attempt to leverage at all? I'm wondering if it might be good to just own stock. [link] [comments]  |
| Any recommendations on audiobooks or podcasts that are good for beginners? Posted: 03 Aug 2021 05:26 AM PDT I am fairly new to the stock market. I have been watching countless videos and reading articles but it seems hard to find a source that is more geared to beginners and helping to increase your initial knowledge of the market. I was just wondering if anyone has any recommendation of audiobooks or podcasts that are helpful for people who are starting to learn about investing. Thanks. [link] [comments]  |
| Visa AMEX & Mastercard vs PayPal, square Posted: 03 Aug 2021 06:13 AM PDT I have been trying to do a lot of research on this, but are PayPal and square a big threat to $MA $V and $AXP? Or is it the other way around that the credit card companies s threaten PayPal and square long term business? Or can all of them exist harmoniously and Keep growing earnings like they have? [link] [comments]  |
| You are subscribed to email updates from Stocks - Investing and trading for all. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment